Heterotopic ossification in the setting of neuromuscular blockade.
暂无分享,去创建一个
S. Krane | P. Merkel | M. Doyle | R. Polisson | G. Perlmutter | T. Goodman
[1] R. Derynck,et al. Toward a molecular understanding of skeletal development , 1995, Cell.
[2] V. Rosen,et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.
[3] V. Rosen,et al. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] N. Clements,et al. Heterotopic ossification complicating critical illness. , 1993, Chest.
[5] R. Sauer,et al. Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty: results in 141 high-risk hips. , 1993, Radiology.
[6] C. DeFlitch,et al. Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. , 1993, Radiology.
[7] W. Maloney,et al. Prophylaxis for heterotopic bone formation after total hip arthroplasty using low-dose radiation in high-risk patients. , 1992, Clinical orthopaedics and related research.
[8] R. Buschbacher,et al. WARFARIN IN PREVENTION OF HETEROTOPIC OSSIFICATION , 1992, American journal of physical medicine & rehabilitation.
[9] A. Reddi,et al. Growth and morphogenetic factors in bone induction: role of osteogenin and related bone morphogenetic proteins in craniofacial and periodontal bone repair. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[10] R. Buschbacher,et al. NONINFLAMMATORY KNEE JOINT EFFUSIONS IN SPINAL CORD‐INJURED AND OTHER PARALYZED PATIENTS Four Case Studies , 1991, American journal of physical medicine & rehabilitation.
[11] S. L. Stover,et al. Experience with surgical resection of heterotopic bone in spinal cord injury patients. , 1991, Clinical orthopaedics and related research.
[12] P. Kjaersgaard-Andersen,et al. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification. , 1991, Clinical orthopaedics and related research.
[13] D. Garland. A clinical perspective on common forms of acquired heterotopic ossification. , 1991, Clinical orthopaedics and related research.
[14] A. Ekelund,et al. Experimental induction of heterotopic bone. , 1991, Clinical orthopaedics and related research.
[15] V. Rosen,et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[16] V. Rosen,et al. Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Garland,et al. Resection of heterotopic ossification in patients with spinal cord injuries. , 1989, Clinical orthopaedics and related research.
[18] M. Brooke,et al. SPECIAL REVIEW NEUROGENIC HETEROTOPIC OSSIFICATION , 1988 .
[19] N. W. Pedersen,et al. Serum Alkaline Phosphatase as an Indicator of Heterotopic Bone Formation Following Total Hip Arthroplasty , 1988, Clinical orthopaedics and related research.
[20] M. Brooke,et al. Neurogenic heterotopic ossification. , 1987, American journal of physical medicine.
[21] F. C. Bauer,et al. High doses of the diphosphonate EHDP for the prevention of heterotopic ossification. An experimental and clinical study. , 1987, Scandinavian journal of rheumatology.
[22] T. Rudd,et al. Heterotopic bone formation: clinical, laboratory, and imaging correlation. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] T. Gennarelli,et al. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. , 1983, Archives of physical medicine and rehabilitation.
[24] D. Garland,et al. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. , 1983, Clinical orthopaedics and related research.
[25] M. Urist,et al. Bone cell differentiation and growth factors. , 1983, Science.
[26] G. Finerman,et al. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP. , 1981, Metabolic bone disease & related research.
[27] J. Michelsson,et al. Myositis ossificans following forcible manipulation of the leg. A rabbit model for the study of heterotopic bone formation. , 1980, The Journal of bone and joint surgery. American volume.
[28] H. Schumacher,et al. Heterotopic ossification mimicking acute arthritis after neurologic catastrophes. , 1977, Archives of internal medicine.
[29] A. Rossier,et al. Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. , 1977, Radiology.
[30] S. L. Stover,et al. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. , 1976, The Journal of bone and joint surgery. American volume.
[31] K. Buring. On the origin of cells in heterotopic bone formation. , 1975, Clinical orthopaedics and related research.
[32] K. Hisada,et al. Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning. , 1974, Radiology.
[33] J. Nicholas,et al. Elevation of the serum alkaline phosphatase coincident with ectopic-bone formation in paraplegic patients. , 1970, The Journal of bone and joint surgery. American volume.
[34] J. Brailsford,et al. The Radiology of Bones and Joints , 1934, The Indian Medical Gazette.